The Party on the Inside: The CCP and Chinese Companies
If China wants its companies to be treated as market-based actors, it needs to be more transparent about efforts to strengthen and expand CCP organizations...
Showing 901 - 912 of 1461
Daniel Russel on China, the “Pivot,” and Rebuilding America’s Standing
The diplomat and Obama aide talks national humility, Biden vs. Trump, and the opportunistic streak of the Chinese Communist Party.
The Logic of U.S.-China Competition
The U.S.-China relationship is a “cooperative rivalry,” in which the terms of competition will require equal attention to both sides of the oxymoron.
Tesla’s China Endgame
For the past few years, observers have watched the China-Tesla love affair with a certain sense of foreboding: how much longer will Beijing allow Tesla...
Cutthroat Competitions
And the quest for leverage.
The Daily Roundup
May 7, 2021 | Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from...
The Daily Roundup
May 6, 2021 | Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from...
The Daily Roundup
May 5, 2021 | Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from...
The Daily Roundup
May 4, 2021 | Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from...
The Daily Roundup
May 3, 2021 | Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from...
Opioid Whack-a-Mole
With the arrival of “iso,” Chinese drug manufacturers have found a new way to tap into America’s huge demand for opioids.
Shots in the Dark
Leaders all across the world have expressed gratitude for China’s ‘vaccine diplomacy’ — especially as the U.S. has been far less forthcoming with its vaccines....